Myxedema Coma
摘要
Insights into the physiology of thyroid hormone deficiency and the elucidation of thyroid hormone action at the cellular and molecular level have improved our understanding of the pathophysiology of myxedema coma. In the past, the mortality rate of this condition was 70–80%. Over the last 10–15 years, however, patients are recognized earlier, receiving intensive supportive care, and are treated with thyroxine early in the course of their illness. These factors have greatly improved the prognosis of myxedema coma and reduced the mortality rate to about 20%.
引用本文（GB/T 7714）
Richard M. Jordan. Myxedema Coma[J]. The Endocrinologist, 1993.
引文网络
本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。